Our customers' Feedback
Search:
Perform search
Categories list

Generic Viread

News
Viread
Viread photo

Generic Viread (Tenofovir Disoproxil Fumarate)

Antivirals, HIV

PackagePricePer PillSavingsOrder
300mg × 30 pills$149.95$5.00Add to cart
300mg × 60 pills$289.95$4.83$9.95Add to cart

Most popular quantity.
Ziagen
$ 6.00
Generic Ziagen
(Abacavir 300mg)
Zovirax
$ 0.64
Generic Zovirax
(Acyclovir 200/400/800mg)
Atripla
$ 324.98
Generic Atripla
(Efavirenz+emtricitabine+tenofovir 600mg + 200mg + 300mg 30 /600mg + 200mg + 300mg 30 pills)
Combivir
$ 1.44
Generic Combivir
(Lamivudine - Zidovudine 150mg + 300mg)
Crixivan
$ 5.20
Generic Crixivan
(Indinavir 400mg)
Efavirenz
$ 0.00
Generic Efavirenz
(Efavirenz 200/500/600mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • ContraVir doses first patients in study of CMX157 against Viread - Seeking Alpha

    ContraVir doses first patients in study of CMX157 against VireadSeeking AlphaContraVir Pharmaceuticals (NASDAQ:CTRV) announces that it has dosed the first patients with chronic hepatitis B in its head-to-head Phase 2a study comparing ContraVir's CMX157 to Gilead Sciences' Viread (tenofovir disoproxil fumarate) (TDF).

  • ContraVir Pharma initiates mid-stage study comparing CMX157 to Gilead's Viread - Seeking Alpha

    ContraVir Pharma initiates mid-stage study comparing CMX157 to Gilead's VireadSeeking AlphaContraVir Pharmaceuticals (NASDAQ:CTRV) commences patient screening for a head-to-head Phase 2a clinical trial comparing CMX157 to Gilead Sciences' (NASDAQ:GILD) Viread (tenofovir disoproxil fumarate or TDF).

  • First Hepatitis B Patients Treated in Study of New Therapy at Lower Doses Than Standard - Hepatitis News Today

    Hepatitis News TodayFirst Hepatitis B Patients Treated in Study of New Therapy at Lower Doses Than StandardHepatitis News TodayTen patients per cohort will be given a once-daily dose of either 5, 10, 25, 50 or 100 mg of CMX157 for 28 days, and two patients per cohort will receive 300 mg of TDF, the standard dose for Viread, for 28 days.

  • ContraVir begin enrollment in head-to-head phase 2a study of CMX157 vs Viread to treat hepatitis B - pharmabiz.com

    ContraVir begin enrollment in head-to-head phase 2a study of CMX157 vs Viread to treat hepatitis Bpharmabiz.

  • Tivicay launch in China coincides with access push - FiercePharma

    Tivicay launch in China coincides with access pushFiercePharma.

    Copyright © cheapgenerics24.com